🇺🇸 FDA
Patent

US 12006363

Anti-tetraspanin 33 agents and compositions and methods for making and using the same

granted A61PA61P35/00A61P37/06

Quick answer

US patent 12006363 (Anti-tetraspanin 33 agents and compositions and methods for making and using the same) held by BioLegend, Inc. expires Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BioLegend, Inc.
Grant date
Tue Jun 11 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 06 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P35/00, A61P37/06